Back

Neural mechanisms underlying release-mode-specific abnormalities in dopamine neural activity in a schizophrenia-like model

Sotoyama, H.

2023-05-09 neuroscience
10.1101/2023.05.09.540082 bioRxiv
Show abstract

Abnormalities in dopamine function might be related to psychiatric disorders such as schizophrenia. Even at the same concentration, dopamine exerts opposite effects on information processing in the prefrontal cortex depending on independent dopamine release modes known as tonic and phasic releases. This duality of dopamine prevents a blanket interpretation of the implications of dopamine abnormalities for diseases on the basis of absolute dopamine levels. Moreover, the mechanisms underlying the mode-specific dopamine abnormalities are not clearly understood. Here, we demonstrate that the two modes of dopamine release in the prefrontal cortex of a schizophrenia-like model are disrupted by different mechanisms. In the schizophrenia-like model established by perinatal exposure to inflammatory cytokine, epidermal growth factor, tonic release was enhanced and phasic release was decreased in the prefrontal cortex. We examined the activity of dopamine neurons in the ventral tegmental area (VTA), which sends dopamine projections to the prefrontal cortex, under anesthesia. The activation of VTA dopamine neurons during excitatory stimulation (local application of glutamate or NMDA), which is associated with phasic activity, was blunt in this model. Dopaminergic neuronal activity in the resting state related to tonic release was increased by disinhibition of the dopamine neurons due to the impairment of 5HT2 (5HT2A) receptor-regulated GABAergic inputs. Moreover, chronic administration of risperidone ameliorated this disinhibition of dopaminergic neurons. These results provide an idea about the mechanism of dopamine disturbance in schizophrenia and may be informative in explaining the effects of atypical antipsychotics as distinct from those of typical drugs. SignificanceI discovered that the hypo-NMDA function occurs in midbrain dopaminergic neurons of a schizophrenia-like model instead of the cerebral cortex, which has been the focus of attention so far. This suggests that the schizophrenia glutamate hypothesis may interact with the dopamine hypothesis. Furthermore, it was elucidated that a subpopulation of dorsal raphe serotonergic neurons inhibits VTA dopaminergic neurons in the resting state, resulting in promotion of social behavior. 5HT2 receptor-mediated regulation of inhibitory inputs to the dopaminergic neurons underlies this serotonergic regulation. In the schizophrenia-like model, this regulation by 5HT2 receptors is impaired. Chronic administration of an atypical antipsychotic ameliorates this abnormality. Therefore, this result may represent a mechanism underlying the differential efficacy between atypical and typical antipsychotics.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Neuropsychopharmacology
153 papers in training set
Top 0.2%
10.8%
2
PLOS ONE
5266 papers in training set
Top 25%
6.6%
3
Neuroscience Letters
32 papers in training set
Top 0.1%
6.6%
4
ACS Chemical Neuroscience
67 papers in training set
Top 0.2%
4.7%
5
Molecular Psychiatry
282 papers in training set
Top 1%
4.7%
6
Progress in Neuro-Psychopharmacology and Biological Psychiatry
48 papers in training set
Top 0.1%
4.7%
7
Behavioural Brain Research
77 papers in training set
Top 0.3%
4.2%
8
British Journal of Pharmacology
40 papers in training set
Top 0.1%
4.2%
9
Scientific Reports
3612 papers in training set
Top 36%
3.2%
10
Translational Psychiatry
260 papers in training set
Top 2%
3.0%
50% of probability mass above
11
Neuropharmacology
68 papers in training set
Top 0.4%
2.7%
12
International Journal of Molecular Sciences
494 papers in training set
Top 4%
2.7%
13
eLife
5828 papers in training set
Top 38%
2.7%
14
Journal of Neuroendocrinology
22 papers in training set
Top 0.1%
2.1%
15
Schizophrenia Research
35 papers in training set
Top 0.2%
1.9%
16
Biomedicines
67 papers in training set
Top 0.9%
1.9%
17
European Journal of Pharmacology
15 papers in training set
Top 0.2%
1.7%
18
Neuroscience
97 papers in training set
Top 0.9%
1.7%
19
Neurochemistry International
10 papers in training set
Top 0.1%
1.6%
20
Biomolecules
100 papers in training set
Top 1%
1.5%
21
Molecular Brain
28 papers in training set
Top 0.2%
1.4%
22
Brain Sciences
55 papers in training set
Top 1%
1.1%
23
Molecular Neurobiology
53 papers in training set
Top 1%
1.0%
24
Parkinsonism & Related Disorders
25 papers in training set
Top 0.4%
1.0%
25
Frontiers in Cellular Neuroscience
91 papers in training set
Top 2%
1.0%
26
European Journal of Neuroscience
189 papers in training set
Top 3%
0.9%
27
Neuroscience Bulletin
12 papers in training set
Top 0.2%
0.8%
28
Frontiers in Pharmacology
111 papers in training set
Top 3%
0.8%
29
Frontiers in Pediatrics
32 papers in training set
Top 1%
0.8%
30
Frontiers in Neuroscience
256 papers in training set
Top 7%
0.8%